Evaluation of the theranostic potential of [64Cu]CuCl2 in glioblastoma spheroids
Catarina I. G. Pinto,André D. M. Branco,Sara Bucar,Alexandra Fonseca,Antero J. Abrunhosa,Cláudia L. da Silva,Joana F. Guerreiro,Filipa Mendes
DOI: https://doi.org/10.1186/s13550-024-01084-8
IF: 3.434
2024-03-09
EJNMMI Research
Abstract:Glioblastoma is an extremely aggressive malignant tumor with a very poor prognosis. Due to the increased proliferation rate of glioblastoma, there is the development of hypoxic regions, characterized by an increased concentration of copper (Cu). Considering this, 64 Cu has attracted attention as a possible theranostic radionuclide for glioblastoma. In particular, [ 64 Cu]CuCl 2 accumulates in glioblastoma, being considered a suitable agent for positron emission tomography. Here, we explore further the theranostic potential of [ 64 Cu]CuCl 2 , by studying its therapeutic effects in advanced three-dimensional glioblastoma cellular models. First, we established spheroids from three glioblastoma (T98G, U373, and U87) and a non-tumoral astrocytic cell line. Then, we evaluated the therapeutic responses of spheroids to [ 64 Cu]CuCl 2 exposure by analyzing spheroids' growth, viability, and cells' proliferative capacity. Afterward, we studied possible mechanisms responsible for the therapeutic outcomes, including the uptake of 64 Cu, the expression levels of a copper transporter (CTR1), the presence of a cancer stem cell population, and the production of reactive oxygen species (ROS).
radiology, nuclear medicine & medical imaging